RCG
MRNA icon

Rock Creek Group’s Moderna MRNA Stock Holding History

Rock Creek Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-62
Closed -$9K – 182
2022
Q2 		$9K Hold
62
– – ﹤0.01% 150
2022
Q1 		$11K Buy
62
+31
+100% +$5.22K ﹤0.01% 158
2021
Q4 		$8K Buy
31
+8
+35% +$2.34K ﹤0.01% 205
2021
Q3 		$9K Buy
+23
New +$8.48K ﹤0.01% 168

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rock Creek Group's MRNA Position: Q3 2022 in Review

Rock Creek Group sold out of Moderna (MRNA) in Q3 2022, closing a stake of 62 shares — an estimated $9K sold.

Rock Creek Group first reported a position in MRNA in Q3 2021 and held it in 4 quarters. The position peaked at $11K in Q1 2022. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Rock Creek Group reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Rock Creek Group sold 62 Moderna shares in Q3 2022, an estimated $9K.
  • Rock Creek Group first reported a position in Moderna in Q3 2021 and held it in 4 quarters.
  • Rock Creek Group's Moderna position peaked at $11K in Q1 2022.
  • 915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Rock Creek Group's 13F filing for Q3 2022, filed 10 Nov 2022.